Intrinsic Value of S&P & Nasdaq Contact Us

Vaccinex, Inc. VCNX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — VCNX

Vaccinex, Inc. (VCNX) has a market capitalization of $3.12M and trades at $1.16. The 52-week range is 0.25-1.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-8.88, annual revenue of $601K.

The stock has a beta of 0.71, operates in the Healthcare sector.

Trading Data
Current Price$1.16
52-Week Range0.25-1.5
Volume615
Avg Volume (30D)2.7K
Market Cap$3.12M
Beta (1Y)0.71
Company
IPO Date2018-08-09
Employees23
CEOMaurice Zauderer
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS9186403013
CUSIP918640103
Income (Latest Year)
Revenue$601K
Gross Profit$601K
EBITDA$-18.54M
Operating Income$-18.74M
Net Income$-18.63M
EPS$-8.88
EPS Diluted$-8.88
Shares Outstanding$2.1M
Balance Sheet (Latest Year)
Total Assets$2.6M
Current Assets$2.53M
Cash & ST Investments$1.11M
Total Liabilities$5.08M
Total Debt$25K
Net Debt$-1.08M
Total Equity$-2.49M
Debt / Equity-0.01
Valuation Ratios
P/E Ratio-0.1
P/S Ratio5.19
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message